FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christophe Bergeron

Research Profile

Living Beings

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

France

Genes & Molecular Sequences

Genes, myc

Co-author Network

Publications

TOP 3
Véronique Minard-Colin; Laurent Nguyen; Daniel Orbach; Angelo Paci; Claudine Schmitt; Nicolas Sirvent; Marie-Dominique Tabone; Nicolas André; Christophe Bergeron; Pascale Blouin; Nadège Corradini; Anne-Sophie Defachelles; Birgit Geoerger; Gisele Goma; Jean-Laurent Ichante; Odile Oberlin
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).
Odile Oberlin; Annie Rey; José Sanchez de Toledo; Marcelo Scopinaro; David Spooner; Christophe Bergeron; Nathalie Bouvet; Caroline Ellershaw; Meriel E M Jenney; Anna Kelsey; Hélène Martelli; Johannes H M Merks; Michael C G Stevens
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Franck Bourdeaut; Delphine Lequin; Laurence Brugières; Stéphanie Reynaud; Christelle Dufour; François Doz; Nicolas André; Jean-Louis Stephan; Yves Pérel; Odile Oberlin; Daniel Orbach; Christophe Bergeron; Xavier Rialland; Paul Fréneaux; Dominique Ranchere; Dominique Figarella-Branger; Georges Audry; Stéphanie Puget; D Gareth Evans; Joan Carles Ferreres Pinas; Valeria Capra; Véronique Mosseri; Isabelle Coupier; Marion Gauthier-Villars; Gaëlle Pierron; Olivier Delattre
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christophe Bergeron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Véronique Minard-Colin; Laurent Nguyen; Daniel Orbach; Angelo Paci; Claudine Schmitt; Nicolas Sirvent; Marie-Dominique Tabone; Nicolas André; Christophe Bergeron; Pascale Blouin; Nadège Corradini; Anne-Sophie Defachelles; Birgit Geoerger; Gisele Goma; Jean-Laurent Ichante; Odile Oberlin
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).
European journal of cancer (Oxford, England : 1990) 2012;48(15):2409-16.
2012: Odile Oberlin; Annie Rey; José Sanchez de Toledo; Marcelo Scopinaro; David Spooner; Christophe Bergeron; Nathalie Bouvet; Caroline Ellershaw; Meriel E M Jenney; Anna Kelsey; Hélène Martelli; Johannes H M Merks; Michael C G Stevens
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(20):2457-65.
2011: Franck Bourdeaut; Delphine Lequin; Laurence Brugières; Stéphanie Reynaud; Christelle Dufour; François Doz; Nicolas André; Jean-Louis Stephan; Yves Pérel; Odile Oberlin; Daniel Orbach; Christophe Bergeron; Xavier Rialland; Paul Fréneaux; Dominique Ranchere; Dominique Figarella-Branger; Georges Audry; Stéphanie Puget; D Gareth Evans; Joan Carles Ferreres Pinas; Valeria Capra; Véronique Mosseri; Isabelle Coupier; Marion Gauthier-Villars; Gaëlle Pierron; Olivier Delattre
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):31-8.
2010: Gudrun Schleiermacher; Isabelle Janoueix-Lerosey; Agnès Ribeiro; Jerzy Klijanienko; Jérôme Couturier; Gaëlle Pierron; Véronique Mosseri; Alexander Valent; Nathalie Auger; Dominique Plantaz; Hervé Rubie; Dominique Valteau-Couanet; Franck Bourdeaut; Valérie Combaret; Christophe Bergeron; Jean Michon; Olivier Delattre
Accumulation of segmental alterations determines progression in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(19):3122-30.
2009: Odile Oberlin; Oumaya Fawaz; Annie Rey; Patrick Niaudet; Vita Ridola; Daniel Orbach; Christophe Bergeron; Annie Sophie Defachelles; Jean-Claude Gentet; Claudine Schmitt; Hervé Rubie; Martine Munzer; Dominique Plantaz; Anne Deville; Veronique Minard; Nadège Corradini; Guy Leverger; Florent de Vathaire
Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5350-5.
2008: M Diepold; Annie Rey; Odile Oberlin; Nathalie Boulay; Christophe Bergeron; Christophe Glorion; Pierre Mary; Marie-José Terrier-Lacombe; Sylvie Helfre; Jean-Louis Habrand; Jean-Claude Gentet; Anne-Sophie Defachelles; Caroline Thomas; Hervé Brisse; Gaëlle Pierron; Daniel Orbach
[Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Bulletin du cancer 2008;95(11):1021-8.
2008: Franck Bourdeaut; Paul Fréneaux; B Thuille; Christophe Bergeron; Valérie Laurence; Laurence Brugières; Cécile Vérité; Jean Michon; Olivier Delattre; Daniel Orbach
Extra-renal non-cerebral rhabdoid tumours.
Pediatric blood & cancer 2008;51(3):363-8.
2008: Christophe Bergeron; Philippe Thiesse; Annie Rey; Daniel Orbach; Patrick Boutard; Caroline Thomas; Claudine Schmitt; Marcelo J Scopinaro; Frederic Bernard; Michael Stevens; Odile Oberlin
Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.
European journal of cancer (Oxford, England : 1990) 2008;44(3):427-31.
2007: Gilles Vassal; Dominique Couanet; Elizabeth Stockdale; Anne Geoffray; Birgit Geoerger; Daniel Orbach; Fabienne Pichon; Jean-Claude Gentet; Susan Picton; Christophe Bergeron; Laura Cisar; Sylvie Assadourian; Bruce Morland
Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):356-61.
2007: Franck Bourdeaut; Paul Fréneaux; B Thuille; Arielle Lellouch-Tubiana; Alain Nicolas; Jérôme Couturier; Gaëlle Pierron; Christian Sainte-Rose; Christophe Bergeron; R Bouvier; Xavier Rialland; Valérie Laurence; Jean Michon; Xavier Sastre-Garau; Olivier Delattre
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
The Journal of pathology 2007;211(3):323-30.
2006: Hervé Rubie; Julia Chisholm; Anne-Sophie Defachelles; Bruce Morland; Caroline Munzer; Dominique Valteau-Couanet; Véronique Mosseri; Christophe Bergeron; Clare Weston; Carole Coze; Anne Auvrignon; Latifa Djafari; Rachel Hobson; Christiane Baunin; Fiona Dickinson; Hervé Brisse; Kieran McHugh; Lorenzo Biassoni; Francesco Giammarile; Gilles Vassal
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5259-64.
2006: Sylvie Brusco; Christophe Bergeron; L Boccon-Gibod; L Claude; Carole Coze; Marc-David Leclair; Julien Carretier; Valérie Delavigne; Béatrice Fervers; Line Leichtnam-Dugarin; Thierry Philip
[Understanding nephroblastoma. Information dedicated to parents and relatives].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2006;10(5):296-312.
2006: Isabelle Flandin; Olivier Hartmann; Jean Michon; Ross Pinkerton; Carole Coze; Jean Louis Stephan; Bernard Fourquet; Dominique Valteau-Couanet; Christophe Bergeron; Thierry Philip; Christian Carrie
Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
International journal of radiation oncology, biology, physics 2006;64(5):1424-31.
2006: C Berger; B Trombert-Paviot; N Mitton; Didier Frappaz; Claire Galambrun; Dominique Plantaz; Stéphanie Dupuis; Yves Bertrand; Noël Philippe; M Schell; P Marec-Bérard; Christophe Bergeron; Corinne Armari-Alla; Anne Pagnier; Jean Louis Stephan; F Freycon
[Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2006;13(2):121-9.
2005: Christophe Bergeron; L Dubourg; Pascal Chastagner; Françoise Mechinaud; Emmanuel Plouvier; A S Desfachelles; F Dusol; Brigitte Pautard; C Edan; Dominique Plantaz; P Froehlich; Hervé Rubie
Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study.
Pediatric blood & cancer 2005;45(1):32-6.
2005: Dominique Valteau-Couanet; Jean Michon; Andrée Boneu; Chantal Rodary; Yves Perel; Christophe Bergeron; Hervé Rubie; Carole Coze; Dominique Plantaz; Frédéric Bernard; Pascal Chastagner; Jeannine Bouzy; Olivier Hartmann
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):532-40.
2004: Christophe Bergeron; Thierry Philip
[Childhood cancer. Epidemiologic, diagnostic, and therapeutic aspects].
La Revue du praticien 2004;54(13):1489-95.
2004: Anne Laprie; Jean Michon; Olivier Hartmann; Caroline Munzer; Marc-David Leclair; Carole Coze; Dominique Valteau-Couanet; Dominique Plantaz; Christian Carrie; Jean-Louis Habrand; Christophe Bergeron; Pascal Chastagner; Anne-Sophie Défachelles; Olivier Delattre; Valérie Combaret; Jean Bénard; Yves Pérel; Virginie Gandemer; Hervé Rubie
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Cancer 2004;101(5):1081-9.
2004: Yves Pérel; Dominique Valteau-Couanet; Jean Michon; F Lavrand; Carole Coze; Christophe Bergeron; A Notz; Dominique Plantaz; Pascal Chastagner; F Bernard; C Thomas; Hervé Rubie
[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2004;11(7):834-42.
2004: Mariana Bohns Michalowski; Hervé Rubie; Jean Michon; S Montamat; Christophe Bergeron; Carole Coze; Yves Perel; Dominique Valteau-Couanet; Joelle Guitard; Jean-Michel Guys; Christian Piolat; Caroline Munzer; Dominique Plantaz
[Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2004;11(7):782-8.
2004: M Meshref; Francois Sassolas; M Schell; L Chalabreysse; C Chassagne; V Mialou; P Marec-Bérard; Sylvie Di Filippo; Christophe Bergeron
Primary cardiac Burkitt lymphoma in a child.
Pediatric blood & cancer 2004;42(4):380-3.
2003: M Haddad; Jean-Michel Triglia; Pierre Helardot; Dominique Couanet; F Gauthier; S Neuenschwander; B Bourlière; Christophe Bergeron; Caroline Munzer; Hervé Rubie; Jean-Michel Guys
Localized cervical neuroblastoma: prevention of surgical complications.
International journal of pediatric otorhinolaryngology 2003;67(12):1361-7.
2003: Hervé Rubie; Carole Coze; Dominique Plantaz; Caroline Munzer; Anne-Sophie Defachelles; Christophe Bergeron; C Thomas; Pascal Chastagner; Dominique Valteau-Couanet; Jean Michon; Véronique Mosseri; Olivier Hartmann
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
British journal of cancer 2003;89(9):1605-9.
2003: Daniel Satgé; Annie J Sasco; Agnès Chompret; Daniel Orbach; Françoise Méchinaud; Brigitte Lacour; Bernard Roullet; Hélène Martelli; Christophe Bergeron; Yves Bertrand; Didier Lacombe; Yves Perel; Pascal Monteil; Brigitte Nelken; Anne-Isabelle Bertozzi; Martine Munzer; Justine Kanold; Fréderic Bernard; Michel J Vekemans; Danièle Sommelet
A 22-year French experience with solid tumors in children with Down syndrome.
Pediatric hematology and oncology 2003;20(7):517-29.
2003: Gudrun Schleiermacher; Hervé Rubie; Olivier Hartmann; Christophe Bergeron; Pascal Chastagner; Françoise Mechinaud; Jean Michon
Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP).
British journal of cancer 2003;89(3):470-6.
2003: Nathalie Gaspar; Olivier Hartmann; Caroline Munzer; Christophe Bergeron; Frédéric Millot; Lucie Cousin-Lafay; Annie Babin-Boilletot; Pascale Blouin; Christine Pajot; Carole Coze
Neuroblastoma in adolescents.
Cancer 2003;98(2):349-55.
2002: Hervé Sartelet; Laurence Grossi; Dominique Pasquier; Valérie Combaret; Raymonde Bouvier; Dominique Ranchère; Dominique Plantaz; Martine Munzer; Thierry Philip; Philippe Birembaut; Jean-Marie Zahm; Christophe Bergeron; Dominique Gaillard; Basile Pasquier
Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
The Journal of pathology 2002;198(1):83-91.
2002: Christophe Bergeron; Dominique Ranchere-Vince; Perrine Berard-Marec
[Update on rhabdomyosarcomas in children].
Bulletin du cancer 2002;89(1):108-12.
2001: Didier Frappaz; P Marec-Bérard; M Schell; E Bouffet; D Rougier; P Blanchard; G Roussin; A Liger; Christophe Bergeron; Thierry Philip; V Zucchinelli
[School reinsertion of children treated for tumors of the brain: experience of the Léon-Bérard center].
Bulletin du cancer 2001;88(12):1222-7.
2001: P Marec-Bérard; D Floret; M Schell; V Mialou; Didier Frappaz; Thierry Philip; Christophe Bergeron
[Immunization for children treated for solid tumors: what are the guidelines?].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2001;8(7):734-43.
2000: V Minard; Olivier Hartmann; MC Peyroulet; Jean Michon; Carole Coze; A S Defachelle; Odile Lejars; Yves Perel; Christophe Bergeron; Patrick Boutard; Guy Leverger; Jean Louis Stephan; Antoine Thyss; Pascal Chastagner; G Couillault; Christine Devalck; Patrick Lutz; Françoise Mechinaud; Frédéric Millot; Dominique Plantaz; Xavier Rialland; Hervé Rubie
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
British journal of cancer 2000;83(8):973-9.
2000: Dominique Plantaz; Jean Michon; Dominique Valteau-Couanet; Carole Coze; Pascal Chastagner; Christophe Bergeron; Brigitte Nelken; Hélène Martelli; MC Peyroulet; A F Carpentier; Corinne Armari-Alla; Anne Pagnier; Hervé Rubie
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2000;7(6):621-8.
1998: François Pein; Jean Michon; Dominique Valteau-Couanet; Erica Quintana; Didier Frappaz; Jean-Pierre Vannier; Thierry Philip; Christophe Bergeron; Marie-Christine Baranzelli; Antoine Thyss; Jean Louis Stephan; Patrick Boutard; Jean-Claude Gentet; Jean-Michel Zucker; MF Tournade; Olivier Hartmann
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3295-301.
1997: Carole Coze; Olivier Hartmann; Jean Michon; Didier Frappaz; F Dusol; Hervé Rubie; Emmanuel Plouvier; Guy Leverger; Pierre Bordigoni; C Béhar; D Beck; Françoise Mechinaud; Christophe Bergeron; Dominique Plantaz; Jacques Otten; Jean-Michel Zucker; Thierry Philip; Jean Louis Bernard
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3433-40.
1997: Hervé Rubie; Olivier Hartmann; Jean Michon; Didier Frappaz; Carole Coze; Pascal Chastagner; Marie-Christine Baranzelli; Dominique Plantaz; H Avet-Loiseau; Jean Bénard; O Delattre; M Favrot; MC Peyroulet; Antoine Thyss; Yves Perel; Christophe Bergeron; B Courbon-Collet; Jean-Pierre Vannier; Jean Lemerle; Danièle Sommelet
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1171-82.
1996: G Michel; André Baruchel; M D Tabone; B Nelken; Thierry Leblanc; Isabelle Thuret; Pierre Bordigoni; Christophe Bergeron; H Esperou-Bourdeau; Yves Perel; Jean-Pierre Vannier; Lionel de Lumley; J P Dommergues; J P Lamagnère; G Couillaud; A Auvrignon; Gérard Schaison; Guy Leverger
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Hematology and cell therapy 1996;38(2):169-76.
1996: Marina Cavazzana-Calvo; Pierre Bordigoni; G Michel; Hélène Esperou; G Souillet; Thierry Leblanc; Jean Louis Stephan; Jean-Pierre Vannier; Françoise Mechinaud; Josy Reiffers; Etienne Vilmer; Judith Landman-Parker; Malika Benkerrou; André Baruchel; J Pico; Françoise Bernaudin; Christophe Bergeron; Emmanuel Plouvier; C Thomas; J Wijdenes; B Lacour; Stéphane Blanche; Alain Fischer
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
British journal of haematology 1996;93(1):131-8.
1996: G Michel; Guy Leverger; Thierry Leblanc; B Nelken; André Baruchel; Judith Landman-Parker; Isabelle Thuret; Christophe Bergeron; Pierre Bordigoni; H Esperou-Bourdeau; Yves Perel; Jean-Pierre Vannier; Gérard Schaison
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Bone marrow transplantation 1996;17(2):191-6.
1995: Justyna Kanold; Marc Berger; Chantal Rapatel; Lionel de Lumley; Patrick Lutz; Dominique Plantaz; Jean-Pierre Vannier; Christophe Bergeron; Françoise Mechinaud; M Favrot
CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass.
British journal of haematology 1995;91(2):431-3.
1993: Pascal Chastagner; D Sommelet-Olive; Chantal Kalifa; M Brunat-Mentigny; Jean-Michel Zucker; F Demeocq; Marie-Christine Baranzelli; P Tron; Christophe Bergeron; François Pein
Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP).
Medical and pediatric oncology 1993;21(1):49-53.
1990: Jean-Claude Gentet; Catherine Patte; Erica Quintana; Christophe Bergeron; Hervé Rubie; François Pein; M C Demaille; T Philip; C Raybaud
Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):661-5.